Pharmaceuticals, Biotechnology and Life Sciences
Statistically and clinically significant effects on pruritus, xanthomas and growth maintained for up to four years of treatment in Alagille…
AXA1665 enhances amino acid metabolism and improves ammonia disposal in subjects with mild and moderate hepatic insufficiency AXA1125 impacts key…
— Data Demonstrate Reductions in Hepatocellular Carcinoma in Hepatitis B (HBV) Patients Treated with Vemlidy — — Improved Markers of…
– exoIL-12 demonstrates tumor-retained and dose-dependent pharmacology with superior anti-tumor efficacy compared to soluble recombinant IL-12 – – exoSTING shows…
LEXINGTON, Mass.–(BUSINESS WIRE)–#LiverMtg19–Fractyl Laboratories Inc. (Fractyl) today announced positive results from the Revita-2 trial evaluating Revita DMR (duodenal mucosal resurfacing)…
— AI-Based Tools for Liver Histology Assessment Contribute to Gilead’s Broader Efforts to Improve Understanding of NASH — — Data…
PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced Phase 2 clinical data on a double combination of JNJ-3989 (formerly…
Pivotal trial will study the intravenous administration of the Company’s Trappsol® Cyclo™ drug and will focus on systemic and neurologic…
Data Presented at the 2019 American College of Allergy, Asthma and Immunology Annual Meeting OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited…
—Despite Differing Study Designs, Patient Criteria and Geographies of the Two Landmark Clinical Trials, Results Were Consistent for AR101-Treated Patients…